Boise State ScholarWorks
metadata only
Novel Association Between Inflammatory Cytokine OSM and Ribosome Biogenesis: OSM Promotes Tumor Progression in HER2- Breast Cancer
In the United States, it is estimated that over 295,000 women will be diagnosed with breast cancer, and over 43,000 breast cancer patients will die in 2025. Mortality in breast cancer is due in large part due to distant metastasis to organs such as the bone, lung, liver, and brain. The IL-6-family c
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer#850480
- A Randomized Study Comparing the Immune Modulation Effect of Ribociclib, Palbociclib, and Abemaciclib in ER+/HER2- EBC#915511
- Changes in Breast Cancer Biomarkers Using Synergistic Prostaglandin Inhibitors#904114
- S9623, Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Women With Breast Cancer#1086137
- Organoids Based Drug Sensitivity in Neoadjuvant Chemotherapy of Breast Cancer#918336
Record · ID 1071600
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive